Cargando…

Antibody Surface Profiling Identifies Glycoforms in Multiple Myeloma as Targets for Immunotherapy: From Antibody Derivatives to Mimetic Peptides for Killing Tumor Cells

SIMPLE SUMMARY: Today, many incurable blood malignancies, such as multiple myeloma (MM), acute myeloid leukemia, and myelodysplastic syndrome, lack effective immunotherapy options. In this study, we used phage display technology to develop candidate therapeutic antibodies targeting cell surface epit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sioud, Mouldy, Olberg, Anniken
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093763/ https://www.ncbi.nlm.nih.gov/pubmed/37046595 http://dx.doi.org/10.3390/cancers15071934

Ejemplares similares

Structural Requirements for the Binding of a Peptide to Prohibitins on the Cell Surface of Monocytes/Macrophages
por: Zhang, Qindong, et al.
Publicado: (2022)

Precision Killing of M2 Macrophages with Phage-Displayed Peptide-Photosensitizer Conjugates
por: Sioud, Mouldy, et al.
Publicado: (2023)

Targeted Killing of Monocytes/Macrophages and Myeloid Leukemia Cells with Pro-Apoptotic Peptides
por: Sioud, Mouldy, et al.
Publicado: (2019)

Releasing the Immune System Brakes Using siRNAs Enhances Cancer Immunotherapy
por: Sioud, Mouldy
Publicado: (2019)

Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activity
por: Calow, Jenny, et al.
Publicado: (2016)

Generation of new peptide-Fc fusion proteins that mediate antibody-dependent cellular cytotoxicity against different types of cancer cells
por: Sioud, Mouldy, et al.
Publicado: (2015)

Unique Glycoform-Dependent Monoclonal Antibodies for Mouse Mucin 21
por: Nishida, Jun, et al.
Publicado: (2022)

Reducing the immunosuppressive tumor microenvironment enhances photoimmunotherapy efficacy
por: Sioud, Mouldy
Publicado: (2021)

Antibody Recognition of Different Staphylococcus aureus Wall Teichoic Acid Glycoforms
por: Di Carluccio, Cristina, et al.
Publicado: (2022)

Cancer cell-binding peptide fused Fc domain activates immune effector cells and blocks tumor growth
por: Mobergslien, Anne, et al.
Publicado: (2016)

Assessment of the role of afucosylated glycoforms on the in vitro antibody-dependent phagocytosis activity of an antibody to Aβ aggregates
por: Kwiatkowski, Allyson, et al.
Publicado: (2020)

Rapid High Yield Production of Different Glycoforms of Ebola Virus Monoclonal Antibody
por: Castilho, Alexandra, et al.
Publicado: (2011)

Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies
por: Storti, Paola, et al.
Publicado: (2020)

RNA Interference
por: Sioud, Mouldy, et al.
Publicado: (2006)

Molecular Basis for the Immunostimulatory Potency of Small Interfering RNAs
por: Sioud, Mouldy, et al.
Publicado: (2006)

Tumor-Associated Macrophage Subsets: Shaping Polarization and Targeting
por: Zhang, Qindong, et al.
Publicado: (2023)

Towards Controlling the Glycoform: A Model Framework Linking Extracellular Metabolites to Antibody Glycosylation
por: Jedrzejewski, Philip M., et al.
Publicado: (2014)

Clearance of therapeutic antibody glycoforms after subcutaneous and intravenous injection in a porcine model
por: Falck, David, et al.
Publicado: (2022)

Computationally profiling peptide:MHC recognition by T-cell receptors and T-cell receptor-mimetic antibodies
por: Raybould, Matthew I. J., et al.
Publicado: (2023)

Selective Killing of Activated T Cells by 5-Aminolevulinic Acid Mediated Photodynamic Effect: Potential Improvement of Extracorporeal Photopheresis
por: Darvekar, Sagar, et al.
Publicado: (2020)

Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond
por: Chim, C S, et al.
Publicado: (2018)

Drug Conjugated and Bispecific Antibodies for Multiple Myeloma: Improving Immunotherapies off the Shelf
por: Barilà, Gregorio, et al.
Publicado: (2021)

Different IVIG Glycoforms Affect In Vitro Inhibition of Anti-Ganglioside Antibody-Mediated Complement Deposition
por: Sudo, Makoto, et al.
Publicado: (2014)

Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma
por: Radocha, Jakub, et al.
Publicado: (2021)

Evidence for the involvement of G(i2) in activation of extracellular signal-regulated kinases in hepatocytes
por: Melien, Øyvind, et al.
Publicado: (2001)

Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond
por: Chim, C. S., et al.
Publicado: (2019)

Antibody Peptide Based Antifungal Immunotherapy
por: Magliani, Walter, et al.
Publicado: (2012)

Antibody-Based Therapies in Multiple Myeloma
por: Tai, Yu-Tzu, et al.
Publicado: (2011)

Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignancies
por: Schriewer, Levin, et al.
Publicado: (2020)

Enzyme-Based Labeling Strategies for Antibody–Drug Conjugates and Antibody Mimetics
por: Falck, Georg, et al.
Publicado: (2018)

Glycoform-resolved pharmacokinetic studies in a rat model employing glycoengineered variants of a therapeutic monoclonal antibody
por: Falck, David, et al.
Publicado: (2020)

Antibody-guided design and identification of CD25-binding small antibody mimetics using mammalian cell surface display
por: See, Kyra, et al.
Publicado: (2021)

Monoclonal Antibodies for the Treatment of Multiple Myeloma: An Update
por: Abramson, Hanley N.
Publicado: (2018)

Immunotherapy for Multiple Myeloma
por: Kröger, Nicolaus, et al.
Publicado: (2012)

Immunotherapy for Multiple Myeloma
por: Tamura, Hideto, et al.
Publicado: (2019)

Immunotherapy in Multiple Myeloma
por: Soekojo, Cinnie Yentia, et al.
Publicado: (2020)

Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms
por: Wada, Ryuta, et al.
Publicado: (2018)

Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple Myeloma
por: Bonello, Francesca, et al.
Publicado: (2019)

Emerging Role of Antibody-Drug Conjugates and Bispecific Antibodies for the Treatment of Multiple Myeloma
por: Tai, Waqqas, et al.
Publicado: (2022)

BH3-profiling identifies heterogeneous dependency on Bcl-2 family members in Multiple Myeloma and predicts sensitivity to BH3 mimetics
por: Touzeau, Cyrille, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uipov3cjc1btnboqvqda9lmthg